News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
518,294 Results
Type
Article (12262)
Company Profile (162)
Press Release (505868)
Multimedia
Podcasts (6)
Webinars (7)
Section
Business (174735)
Career Advice (561)
Deals (26708)
Drug Delivery (24)
Drug Development (54383)
Employer Resources (33)
FDA (10284)
Job Trends (9479)
News (248713)
Policy (19144)
Tag
2025 Best Places to Work (6)
2026 Best Places to Work (12)
2027 BioCapital Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Standard (1)
40 Under 40 (2)
Academia (978)
Accelerated approval (32)
ADA (18)
Adcomms (1)
Allergies (109)
Alliances (35704)
ALS (132)
Alzheimer's disease (1119)
Antibody-drug conjugate (ADC) (371)
Approvals (11024)
Artificial intelligence (565)
ASCO (163)
Autoimmune disease (279)
Automation (60)
Bankruptcy (274)
Belgium (5)
Best Places to Work (7450)
BIO (40)
Biologics (69)
BIOSECURE Act (2)
Biosimilars (147)
BioSpace Insights (41)
Biotechnology (96)
Bispecific (34)
Bladder cancer (152)
Brain cancer (40)
Breast cancer (578)
Cancer (4429)
Cardiovascular disease (277)
Career advice (477)
Career pathing (18)
CAR-T (211)
CDC (7)
CDMO (55)
Celiac Disease (3)
Cell therapy (589)
Cervical cancer (50)
Clinical research (49616)
Collaboration (1598)
Commercialization (39)
Compensation (1681)
Complete response letters (38)
COVID-19 (1082)
CRISPR (93)
CRO (1)
C-suite (939)
Cystic fibrosis (101)
Data (7049)
Denatured (5)
Depression (113)
Dermatology (111)
Diabetes (406)
Diagnostics (5270)
Digital health (49)
Diversity (2)
Diversity, equity & inclusion (7)
Drug discovery (255)
Drug pricing (13)
Drug shortages (5)
Duchenne muscular dystrophy (178)
Earnings (75868)
Editorial (5)
Employer branding (4)
Employer resources (31)
ESMO (247)
Events (92315)
Executive appointments (802)
Eye disease (8)
FDA (13411)
Fibrodysplasia Ossificans Progressiva (12)
Fragile X (1)
Friedreich's ataxia (22)
Frontotemporal dementia (27)
Funding (1217)
Gene editing (166)
Generative AI (33)
Gene therapy (398)
GLP-1 (377)
Government (1346)
Grass and pollen (3)
Guidances (299)
Healthcare (10396)
Hematology (122)
HIV (68)
Huntington's disease (31)
Idiopathic pulmonary fibrosis (6)
IgA nephropathy (84)
Immunology and inflammation (134)
Immuno-oncology (79)
Indications (193)
Infectious disease (1318)
Inflammatory bowel disease (159)
Inflation Reduction Act (4)
Influenza (108)
Intellectual property (286)
Interviews (79)
IPO (12757)
IRA (6)
Job creations (2333)
Job search strategy (421)
JPM (12)
Kidney cancer (19)
Kidney disease (98)
Labor market (30)
Layoffs (105)
Leadership (21)
Legal (5382)
Licensing (72)
Liver cancer (49)
Longevity (35)
Lung cancer (625)
Lung diease (12)
Lymphoma (307)
Machine learning (47)
Management (8)
Manufacturing (749)
Marketing (25)
MASH (133)
Medical affairs (2)
Medical device (9258)
Medtech (9478)
Mergers & acquisitions (15176)
Metabolic disorders (847)
Middle East (1)
mRNA (104)
Multiple sclerosis (122)
Multispecific (4)
NASH (4)
Netherlands (8)
Neurodegenerative disease (269)
Neuropsychiatric disorders (44)
Neuroscience (2174)
Neurotech (3)
NextGen: Class of 2026 (3568)
Non-profit (1306)
Now hiring (27)
Obesity (278)
Opinion (74)
Ovarian cancer (193)
Pain (205)
Pancreatic cancer (254)
Parkinson's disease (240)
Partnered (23)
Patents (545)
Patient advocacy (3)
Patient recruitment (568)
Patient selection (60)
Peanut (37)
People (43763)
Peptides (30)
Pharmaceutical (31)
Pharmacy benefit managers (11)
Phase 1 (16048)
Phase 2 (22138)
Phase 3 (15051)
Pipeline (9615)
Policy (41)
Postmarket research (1630)
Preclinical (6882)
Press Release (44)
Prostate cancer (223)
Psychedelics (20)
Radiopharmaceuticals (218)
Rare diseases (692)
Real estate (3898)
Recruiting (15)
Regenerative medicine (21)
Regulatory (16179)
Reports (33)
Research institute (1069)
Resumes & cover letters (73)
Rett syndrome (51)
RNA editing (11)
RSV (57)
Saudi Arabia (1)
Schizophrenia (118)
Series A (216)
Series B (149)
Service/supplier (5)
Sickle cell disease (72)
Special edition (6)
Spinal muscular atrophy (96)
Sponsored (13)
Startups (2352)
Stem cells (5)
Stomach cancer (5)
Substance use disorders (17)
Supply chain (68)
Switzerland (2)
Tariffs (6)
Tax incentives (1)
The Weekly (1)
Vaccines (416)
Venture capital (55)
Weight loss (100)
Wet AMD (3)
Women's health (112)
Worklife (6)
Date
Today (129)
Last 7 days (603)
Last 30 days (2586)
Last 365 days (20404)
2026 (18544)
2025 (20340)
2024 (24255)
2023 (28074)
2022 (36596)
2021 (39315)
2020 (36395)
2019 (25748)
2018 (19158)
2017 (20309)
2016 (19621)
2015 (25860)
2014 (22798)
2013 (19183)
2012 (21289)
2011 (21516)
2010 (20950)
Location
Africa (320)
Alabama (88)
Alaska (3)
Arizona (348)
Arkansas (12)
Asia (20209)
Australia (2425)
California (13865)
Canada (3570)
China (703)
Colorado (583)
Connecticut (535)
Delaware (262)
Europe (29943)
Florida (2041)
Georgia (444)
Hawaii (3)
Idaho (47)
Illinois (863)
India (82)
Indiana (393)
Iowa (28)
Japan (484)
Kansas (114)
Kentucky (41)
Louisiana (32)
Maine (28)
Maryland (1384)
Massachusetts (9155)
Michigan (338)
Minnesota (640)
Mississippi (6)
Missouri (119)
Montana (22)
Nebraska (12)
Nevada (151)
New Hampshire (68)
New Jersey (3086)
New Mexico (21)
New York (3295)
North Carolina (1482)
North Dakota (8)
Northern California (7025)
Ohio (370)
Oklahoma (15)
Oregon (22)
Pennsylvania (2557)
Puerto Rico (25)
Rhode Island (41)
South America (556)
South Carolina (85)
South Dakota (1)
Southern California (5785)
Tennessee (176)
Texas (2301)
United States (45337)
Utah (447)
Vermont (1)
Virginia (184)
Washington D.C. (43)
Washington State (1088)
West Virginia (3)
Wisconsin (108)
Wyoming (4)
518,294 Results for "paladin labs inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Funding
Isomorphic Labs breaks biotech VC fundraising record with $5B series C
After securing $2.1 billion this May, AI-driven drug designer Isomorphic Labs is back with more money—a lot more—securing the industry’s largest private fundraise ever.
November 17, 2026
·
1 min read
·
Gabrielle Masson
Press Releases
Veedma Launches Free Doctor-Reviewed Lab Analysis for Men’s Hormone Health
Men can turn recent lab results into a personalized clinical report from a licensed doctor and understand the cause before considering treatment.
September 3, 2026
·
1 min read
Press Releases
Shattuck Labs, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - November 12, 2026
November 12, 2026
·
1 min read
Endo’s Paladin Labs Announces Launch of XCOPRI® (cenobamate tablets) in Canada
Paladin Labs Inc., a subsidiary of Endo International plc (OTC: ENDPQ), announced today that XCOPRI® (cenobamate tablets) is now available in Canada.
January 22, 2024
·
7 min read
Press Releases
Transformative Biotech Joins HudsonAlpha’s Primer Lab
October 29, 2026
·
2 min read
Press Releases
Isomorphic Labs announces $5 Billion Series C funding
November 17, 2026
·
4 min read
Press Releases
Paragon Labs Expands Leadership Team with Former Apogee Executives; Velaris Therapeutics Acquired by Alaunos Therapeutics, Inc.
October 13, 2026
·
4 min read
Press Releases
Theriva™ Biologics Announces Sale of SYN-004 (ribaxamase) and Related Antibiotic-Degrading Enzyme Portfolio to Biossil Labs Inc.
November 2, 2026
·
10 min read
Press Releases
BioAge Labs to Present at Upcoming November 2026 Investor Conferences
November 11, 2026
·
2 min read
Press Releases
Ginkgo Bioworks to Provide Autonomous Lab Access to NSF X-Labs Researchers, Contributing Cloud Lab Time and Protein Testing Services to $1.5 Billion Breakthrough Science Program
October 8, 2026
·
6 min read
1 of 51,830
Next